From the CME Institute

John Lauriello, MD

Brief Report | Earn 0.50 Credit
(Expires 03/31/2022)

Prevalence and Impact of Relapse in Patients With Schizophrenia

Madhukar H. Trivedi, MD

Brief Report | Earn 0.50 Credit
(Expires 03/31/2022)

How Can Measurement-Based Care Help Improve Treatment Outcomes for Major Depressive Disorder in Primary Care?

Madhukar H. Trivedi, MD

Brief Report | Earn 0.50 Credit
(Expires 03/31/2022)

Major Depressive Disorder in Primary Care: Strategies for Identification

Leslie L. Citrome, MD, MPH

Brief Report | Earn 0.50 Credit
(Expires 01/31/2022)

Medication Options and Clinical Strategies for Treating Tardive Dyskinesia

Stephen R. Saklad, PharmD, BCPP

Brief Report | Earn 0.50 Credit
(Expires 12/31/2021)

Identifying Tardive Dyskinesia: Risk Factors, Functional Impact, and Diagnostic Tools

Trisha Suppes, MD, PhD

Brief Report | Earn 0.50 Credit
(Expires 12/31/2021)

Strategies for Shifting From Acute to Maintenance Treatment for Bipolar I Disorder

Stuart H. Isaacson, MD

Brief Report | Earn 1.00 Credit
(Expires 12/31/2021)

Effective Treatment Strategies for Motor and Nonmotor Symptoms of Parkinson Disease

Stuart H. Isaacson, MD

Brief Report | Earn 0.50 Credit
(Expires 12/31/2021)

Early Recognition and Diagnosis of Parkinson Disease and Ongoing Assessments

Trisha Suppes, MD, PhD

Brief Report | Earn 0.50 Credit
(Expires 12/31/2021)

Evidence-Based Treatment Targets, Selection, and Strategies for Acute Manic and Mixed Episodes of Bipolar I Disorder

Daniel E. Kremens, MD, JD

Brief Report | Earn 0.50 Credit
(Expires 11/30/2021)

Treatment Strategies for Tardive Dyskinesia

Daniel E. Kremens, MD, JD

Brief Report | Earn 0.50 Credit
(Expires 11/30/2021)

Earlier Diagnosis of Tardive Dyskinesia

Joseph P. McEvoy, MD

Brief Report | Earn 0.50 Credit
(Expires 11/30/2021)

FDA-Approved Medications to Treat Tardive Dyskinesia

Joseph P. McEvoy, MD

Brief Report | Earn 0.50 Credit
(Expires 10/31/2021)

Psychosocial Implications of Tardive Dyskinesia in Patients With Mood Disorders Versus Schizophrenia

Alireza Atri, MD, PhD; Simon Sheard, DO; and Danielle Goldfarb, MD

Webcast | Earn 1.00 Credit
(Expires 08/31/2021)

A Multidisciplinary Approach for Addressing Challenges in Alzheimer's Disease

More ways to earn credit

The Official Journal of The American Society of Clinical Psychopharmacology

JCP Weekly

Clinical and Practical Psychopharmacology

The Use and Limitations of the Fragility Index in the Interpretation of Clinical Trial Findings

J Clin Psychiatry 2020;81(2):20f13334

Original Research

Metabolic Effects of 7 Antipsychotics on Patients With Schizophrenia: A Short-Term, Randomized, Open-Label, Multicenter, Pharmacologic Trial

J Clin Psychiatry 2020;81(3):19m12785

Meta-Analysis

Effect of Continuing and Discontinuing Medications on Quality of Life After Symptomatic Remission in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis [Free]

J Clin Psychiatry 2020;81(3):19r13015

Letter to the Editor

Behavioral Symptoms Improve Prediction Models of Mortality in Patients With Dementia [Free]

J Clin Psychiatry 2020;81(3):19lr13217

Letter to the Editor

Dr Cheng and Colleagues Reply [Free]

J Clin Psychiatry 2020;81(3):19lr13217a

Educational Activity | Earn Credit

Prevalence and Impact of Relapse in Patients With Schizophrenia

J Clin Psychiatry 2020;81(2):MS19053BR1C

Original Research

Types of Adult Attention-Deficit/Hyperactivity Disorder: A Replication Analysis [Free]

J Clin Psychiatry 2020;81(2):19m13077

Original Research

Course of Psychosis in Schizophrenia With Alcohol Use Disorder: A Post Hoc Analysis of the Clinical Antipsychotic Trials of Intervention Effectiveness in Schizophrenia Phase 1 Study

J Clin Psychiatry 2020;81(2):19m12731

See all JCP Weekly

Did you know?

Find out more

Blog

Let's Talk Blog

Browse by Topic